Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Researchers presented 100-week data on a trial of the antiretroviral (ARV) regimen at the international AIDS conference.
During that time, the rate dropped 15 percent nationally and rose 25 percent among Latino men who have sex with men.
The new drug application is for doravirine as both an individual tablet and part of a combination tablet.
The news first broke in February about a man in Amsterdam who contracted non-drug-resistant HIV while apparently adhering well to PrEP.
Other factors linked to a reduced risk of death include a hep C cure, less advanced liver disease, not smoking and well treated HIV.
An increasing proportion of those living with HIV are in care and on successful treatment, but there is still much room for improvement.
Maryland, Pennsylvania, Georgia and New York saw at least a 5 percent yearly rate of decline in new cases between 2008 and 2014.
The science behind Truvada as pre-exposure prophylaxis reveals an awesome tool that is apparently already helping shrink U.S. HIV rates.
Gazing into the crystal ball at the epidemic’s future reveals many exciting advancements. Lower infection rates is just the beginning.
TaiMed Biologics has applied for approval of the weekly injectable antibody ibalizumab for those with multidrug-resistant virus.
With a likely increasing proportion of the HIV population virally suppressed, addressing disparities, especially racial ones, is vital.
A study in Mozambique found that providing on-site CD4 testing, speedier HIV treatment initiation and text-message reminders was effective.
A risk calculator based on factors such as fever and swollen lymph nodes identified three quarters of early HIV cases in a Dutch cohort.
In contrast to the only person cured of HIV, this man did not have a donor with a genetic abnormality conferring HIV resistance.
But not as well as those with compensated cirrhosis or no cirrhosis.
However, in a recent study those who had been treated for hep C before did not fare as well.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.